|How Cellma can help manage diabetes care|
The National Diabetes Audit, a Government commissioned report, found up to 24,000 people with diabetes die unnecessarily each year.
The risk of death for patients with Type 1 diabetes is 2.6 times higher than the general population, for patients with type 2 diabetes the risk is 1.6 times higher (National Diabetes Audit Mortality Analysis 2007-2008).
Young women are particularly high risk. Women aged 15 to 34, with type 1 diabetes are nine times more likely to die than the national population average for this age range, and six times more likely for those with type 1 diabetes. Men in this age range, with either type 1 or 2 diabetes, have a nine fold risk of death (NHS The Information Centre, 2011).
Whilst the study did not assess the cause of finding it is widely accepted that better long term disease management would significantly reduce risk.
RioMed currently provide software services over 150 UK sites, 60 NHS Trusts, 60% of all Irish hospitals and 50 sites in the Caribbean. RioMed’s flagship software Cellma provides full clinical and managerial functionality and can assist health services in bringing down these startling figures. Furthermore RioMed have recently been awarded the Single Supplier Framework for use by diabetes services in Ireland.
Here are some of the ways Cellma can help ensure better management of diabetes care;
Ensure follow ups
Cellma’s automated recall functionality ensures patients are reviewed should any investigation demonstrate an abnormal result over a specified threshold. If such a result is returned Cellma will automatically identify this, flag it to the attention of the clinician and text the patient inviting them for a follow up appointment.
Improve annual review attendance rates
Cellma records appointment dates and automatically generates review appointment reminders. These reminders are automatically sent to the patient prompting them to book an appointment. Should the patient fail to make an appointment this will be flagged for the attention of the service who can then follow up the patient.
Standardised best practice assessments promote quality across services
Evidence based best practice assessments used in Cellma standardise care across the entire multidisciplinary team. This raises the quality of patient data, ensuring all check-ups are carried out and recorded, for example the following annual checks;
Cellma will also report patient sequential data and graph results over time.
Promotes compliance with NICE guidance
Cellma facilitates the meeting of all relevant NICE guidelines through ensuring all required data is collected and reported on, patients receive appropriate information and that communication across the multidisciplinary team is strong. This includes but is not limited to; CG10, CG15, CG63, CG66, TA53, TA60, TA151 and TA203
Ensure patients with diabetes receive education about the disease
Cellma can monitor the number diabetic adults who have been offered, have started or completed structured education, monitor those patients whose structured education has been reviewed and reinforced and manage the electronic design and recording of educational programs in line with DOH and Diabetes UK Patient Education Working Group.
Sharing of information across the MDT
Cellma is accessible from any NHS terminal ensuring the entire multidisciplinary team have 24/7/365 real time access to patient records. This promotes informed decision making and ensures appropriate care for diabetes patients regardless of the location.
Comprehensive GP letters and patient summaries generated after every contact with the patient
Data gathered at the point of contact with the patient automatically populates a letter template (predefined by the service). This can then be approved and sent within 24 hours ensuring rapid follow up and appropriate care with the GP and entire multidisciplinary team. This function improves communication lines and reduces the administrative burden.
Full integration and information sharing with external services, including Podiatry, Dietetics and Nephrology
Cellma is fully interoperable with third party systems ensuing seamless referrals and information sharing with external services.
Cellma monitors data quality through accurate and concise reporting on any aspect of the solution, adhering to national, statutory and locally defined requirements. There are three levels of reporting available:
Comprehensive register of all diabetic patients
Included in Cellma’s reporting module is the capability to produce a comprehensive master patient index including all patients within a specified geoprahpial area. This can be used to measure disease prevalence and assist service managers in effective resource utilisation planning.
Rapid identification of patients suitable for research
Cellma’s advanced patient search identifies cohorts of patients by any specified characteristics, including demographic and clinical information. Suitable patients can then be approached for research studies. Cellma can also be used as a research tool during a project, collecting information and reporting on outcomes and trends at the click of a button, or at predefined intervals. This not only allows researchers to use one system across consultation and research, but also ensures data recapture and analysis is a quick and easily understood process. This facilitates the monitoring and improving of long term care and patterns of diabetes implications